blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3411689

EP3411689 - SYSTEM AND METHOD FOR OPTICAL ABSORBANCE MEASUREMENT OF WHOLE BLOOD [Right-click to bookmark this link]
Former [2018/50]ANALYTE SYSTEM AND METHOD FOR DETERMINING HEMOGLOBIN PARAMETERS IN WHOLE BLOOD
[2022/08]
StatusNo opposition filed within time limit
Status updated on  12.05.2023
Database last updated on 14.06.2024
FormerThe patent has been granted
Status updated on  03.06.2022
FormerGrant of patent is intended
Status updated on  03.02.2022
FormerExamination is in progress
Status updated on  20.11.2020
FormerRequest for examination was made
Status updated on  09.11.2018
FormerThe international publication has been made
Status updated on  11.08.2017
Most recent event   Tooltip16.02.2024Lapse of the patent in a contracting state
New state(s): BE		published on 20.03.2024  [2024/12]
Applicant(s)For all designated states
Nova Biomedical Corporation
200 Prospect Street
Waltham, MA 02454 / US
[2018/50]
Inventor(s)01 / CAFFERTY, Michael
7 Richard Street
Medford, Massachusetts 02155 / US
02 / CIONEK, Scott P.
79 Woobly Road
Bolton, Massachusetts 01740 / US
 [2018/50]
Representative(s)Katérle, Axel
Wuesthoff & Wuesthoff
Patentanwälte PartG mbB
Schweigerstraße 2
81541 München / DE
[2018/50]
Application number, filing date16889601.704.02.2016
[2018/50]
WO2016US16560
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017135952
Date:10.08.2017
Language:EN
[2017/32]
Type: A1 Application with search report 
No.:EP3411689
Date:12.12.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 10.08.2017 takes the place of the publication of the European patent application.
[2018/50]
Type: B1 Patent specification 
No.:EP3411689
Date:06.07.2022
Language:EN
[2022/27]
Search report(s)International search report - published on:KR10.08.2017
(Supplementary) European search report - dispatched on:EP20.12.2019
ClassificationIPC:G01N21/01, G01N21/17, G01N15/05, A61B5/145, G01J3/02, G01J3/10, G01J3/14, G01J3/42, G01N21/03, G01N21/27, G01N21/31, G01N21/49, G01N21/21, G01N33/49
[2022/08]
CPC:
G01N21/274 (EP,KR); G01N21/31 (EP,KR); A61B5/14535 (EP);
A61B5/1455 (EP); A61B5/14557 (EP); A61B5/14558 (EP);
G01J3/0202 (EP); G01J3/0205 (EP); G01J3/0208 (EP);
G01J3/0286 (EP); G01J3/0291 (EP); G01J3/10 (EP);
G01J3/14 (EP); G01J3/18 (EP); G01J3/42 (EP,KR);
G01N21/01 (RU); G01N21/0303 (EP,KR); G01N21/359 (EP);
G01N33/492 (EP,KR); G01J5/0878 (KR); G01N2021/216 (EP,KR);
G01N2201/062 (EP,KR); G01N2201/0634 (EP,KR) (-)
Former IPC [2019/41]G01N21/01, G01N21/17, G01N15/05, A61B5/145, G01J3/02, G01J3/10, G01J3/14, G01J3/42, G01N21/03, G01N21/27, G01N21/31, G01N21/49, G01N21/21
Former IPC [2018/50]G01N21/01, G01N21/17, G01N15/05
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/50]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:SYSTEM UND VERFAHREN ZUR OPTISCHEN EXTINKTIONSMESSUNG VON VOLLBLUT[2022/08]
English:SYSTEM AND METHOD FOR OPTICAL ABSORBANCE MEASUREMENT OF WHOLE BLOOD[2022/08]
French:SYSTÈME ET PROCÉDÉ DE MESURE D'ABSORPTION OPTIQUE DE SANG TOTAL[2022/08]
Former [2018/50]ANALYTSYSTEM UND VERFAHREN ZUR BESTIMMUNG VON HÄMOGLOBINPARAMETERN IN VOLLBLUT
Former [2018/50]ANALYTE SYSTEM AND METHOD FOR DETERMINING HEMOGLOBIN PARAMETERS IN WHOLE BLOOD
Former [2018/50]SYSTÈME D'ANALYTE ET PROCÉDÉ DE DÉTERMINATION DE PARAMÈTRES DE L'HÉMOGLOBINE DANS LE SANG TOTAL
Entry into regional phase06.08.2018National basic fee paid 
06.08.2018Search fee paid 
06.08.2018Designation fee(s) paid 
06.08.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
06.08.2018Examination requested  [2018/50]
08.07.2020Amendment by applicant (claims and/or description)
24.11.2020Despatch of a communication from the examining division (Time limit: M04)
26.02.2021Reply to a communication from the examining division
20.01.2022Cancellation of oral proceeding that was planned for 11.02.2022
04.02.2022Communication of intention to grant the patent
11.02.2022Date of oral proceedings (cancelled)
27.05.2022Fee for grant paid
27.05.2022Fee for publishing/printing paid
27.05.2022Receipt of the translation of the claim(s)
Divisional application(s)EP22174592.0  / EP4067867
EP22174601.9  / EP4067868
EP22174613.4  / EP4067869
EP22174620.9  / EP4071460
Opposition(s)11.04.2023No opposition filed within time limit [2023/24]
Fees paidRenewal fee
06.08.2018Renewal fee patent year 03
26.02.2019Renewal fee patent year 04
27.02.2020Renewal fee patent year 05
25.02.2021Renewal fee patent year 06
24.02.2022Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL06.07.2022
AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
IE04.02.2023
LU04.02.2023
BE28.02.2023
CH28.02.2023
LI28.02.2023
[2024/12]
Former [2024/08]AL06.07.2022
AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
IE04.02.2023
LU04.02.2023
CH28.02.2023
LI28.02.2023
Former [2023/49]AL06.07.2022
AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
LU04.02.2023
CH28.02.2023
LI28.02.2023
Former [2023/48]AL06.07.2022
AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
CH28.02.2023
LI28.02.2023
Former [2023/44]AL06.07.2022
AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/37]AL06.07.2022
AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/29]AL06.07.2022
AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/23]AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/22]AT06.07.2022
CZ06.07.2022
DK06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/21]DK06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RS06.07.2022
SE06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/20]FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RS06.07.2022
SE06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/12]FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RS06.07.2022
SE06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/11]FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RS06.07.2022
SE06.07.2022
NO06.10.2022
GR07.10.2022
PT07.11.2022
Former [2023/10]FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
RS06.07.2022
SE06.07.2022
NO06.10.2022
GR07.10.2022
PT07.11.2022
Former [2023/09]FI06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
RS06.07.2022
SE06.07.2022
NO06.10.2022
PT07.11.2022
Former [2023/08]FI06.07.2022
LT06.07.2022
NL06.07.2022
RS06.07.2022
SE06.07.2022
NO06.10.2022
Former [2023/06]NL06.07.2022
Documents cited:Search[Y]US1143675  (WHITNEY JAMES L [US]) [Y] 3-5,11,12 * figures 2-3, 6 *;
 [A]US2850941  (LONG WALTER K) [A] 3-5,11,12* figure 1 *;
 [A]US3569721  (GOLDBERG HERBERT E, et al) [A] 3-5,11,12 * figure 1 *;
 [Y]JPS5928642  (HITACHI LTD) [Y] 3-5,11,12 * figures 1,4 *;
 [A]US5934278  (ISHIHARA KEN [JP], et al) [A] 3-5,11,12 * figure 1 *;
 [A]US6049727  (CROTHALL KATHERINE D [US]) [A] 1,2 * figure 1 *;
 [A]US6235241  (CATT MICHAEL [GB], et al) [A] 3-5,11,12 * figure 3 *;
 [Y]US2005094127  (O'MAHONY JOHN J [IE], et al) [Y] 2-5,11,12 * [0011], [0056];; figure 9 *;
 [A]US2005259254  (SOLLER BABS R [US], et al) [A] 1,2 * figures 1-2 *;
 [A]CN1268916C  (UNIV SHANGHAI JIAOTONG [CN]) [A] 1,2 * figure 2 *;
 [A]US2007060810  (HIGGINS MICHAEL J [US]) [A] 1,2 * figures 5-6 *;
 [Y]US2008274554  (STIMPFL PETER [AT], et al) [Y] 2 * [0027], [0036];; figure 1 *;
 [A]US2009079965  (FORSELL TOMMY [SE], et al) [A] 1,2 * figures 1-2 *;
 [Y]WO2012116336  (FRESENIUS MED CARE HLDG INC [US], et al) [Y] 3-5,11,12 * [0065], [0112]-[0112];; figures 21A-21B *;
 [A]WO2015076262  (ARAI MEDPHOTON RES LAB CORP [JP]) [A] 3-5,11,12 * figures 1,9,19 *;
 [IY]US2015316471  (ANDERSEN WILLY LINDEGAARD [DK], et al) [I] 1 * [0001]-[0002], [0016], [0024], [0057]-[0059], [0061], [0064]-[0070], [0073], [0075]-[0076], [0092];; figures 1-2,4 * [Y] 2-5,11,12
International search[Y]US4310249  (KRAMER DONALD L) [Y] 2-6, 13-15 * See column 2, lines 18-53 and figure 1. *;
 [Y]US6650412  (SLATER JOSEPH B [US]) [Y] 7-9, 11, 12* See column 4, lines 1-25, claim 1 and figure 2. *;
 [YA]US2005037505  (SAMSOONDAR JAMES [CA]) [Y] 1-15 * See paragraphs [0196]-[0250], claim 1 and figures 5a-8. * [A] 16-18;
 [Y]JP2009053029  (OLYMPUS CORP) [Y] 1-3 * See paragraphs [0016], [0030]. *;
 [Y]US2015021480  (CHRISP MICHAEL P [US]) [Y] 6-12 * See paragraph [0030] and figure 1. *
by applicantUS2015316471
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.